Tracheal Occlusion Guided by Percutaneous Fetoscopy in Fetuses With Severe Isolated Congenital Diaphragmatic Hernia
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Congenital Diaphragmatic Hernia
- Sponsor
- University of Sao Paulo General Hospital
- Enrollment
- 36
- Locations
- 1
- Primary Endpoint
- Survival rate
- Last Updated
- 15 years ago
Overview
Brief Summary
The neonatal mortality rate in cases with severe isolated congenital diaphragmatic hernia is higher than 90% due to severe pulmonary hypoplasia. Many studies have suggested that fetal tracheal occlusion may increase lung volumes and therefore reducing the risk for severe pulmonary hypoplasia and by consequence the risk for neonatal death.
The main objective of the present study is to evaluate if fetal tracheal occlusion improves survival rate in those cases that are followed in our hospital, by conducing a randomized trial.
Detailed Description
Fetuses will be randomly allocated in two groups: 1. for fetal tracheal occlusion at 26-28 weeks (FETO group) or 2. Postnatal therapy only (Control) Main outcome: Survival rate in both groups Second outcomes: Postnatal diagnosis of severe pulmonary arterial hypertension, percentage of newborns in each group that will have clinical conditions for neonatal surgical repair of the diaphragmatic defect, fetal lung responses (increase of fetal lung size), maternal and obstetrical complications (prematurity, preterm rupture of the membranes, maternal hemorrhage and infection).
Investigators
Eligibility Criteria
Inclusion Criteria
- •ultrasound diagnosis of congenital diaphragmatic hernia
- •fetuses at gestational age between 24 and 28 weeks
- •absence of chromosomal and/or other structural anomalies (isolated congenital diaphragmatic hernia)
- •severe congenital diaphragmatic hernia defined by lung-head ratio \< 1.0 and more than 1/3 of liver herniated into fetal thorax and observed/expected fetal total lung volume \< 0.35
- •patient's consent to participate in the present study
Exclusion Criteria
- •Patient's refusal to participate in the study after allocation
- •Preterm labor diagnosed before the procedure
- •Preterm rupture of membranes before fetal intervention
Outcomes
Primary Outcomes
Survival rate
Time Frame: 1 year
Noenatal survival rate which includes percentage of newborns that survive up to 30 days of life. Infant survival rate which includes percentage of newborns that survive up to one year of life. Outcome measurement will be assessed up to one year after birth.
Secondary Outcomes
- Postnatal pulmonary arterial hypertension(30 days of life)